Showing 1 of 1 PublicationsInfliximab in graft-versus-host diseaseRivkina A, Stump L. Infliximab in graft-versus-host disease. American Journal Of Health-System Pharmacy 2002, 59: 1271-1275. PMID: 12116893, DOI: 10.1093/ajhp/59.13.1271.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsMeSH KeywordsAdolescentAdultAntibodies, MonoclonalFemaleGastrointestinal AgentsGraft vs Host DiseaseHumansInfliximabLiverMaleMiddle AgedTreatment OutcomeConceptsDrug reactionsSerious adverse drug reactionsAdverse drug reactionsHost diseasePatient casesGrand roundsDrug experienceReportInfliximabReviewGraftDownload Full List
Infliximab in graft-versus-host diseaseRivkina A, Stump L. Infliximab in graft-versus-host disease. American Journal Of Health-System Pharmacy 2002, 59: 1271-1275. PMID: 12116893, DOI: 10.1093/ajhp/59.13.1271.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsMeSH KeywordsAdolescentAdultAntibodies, MonoclonalFemaleGastrointestinal AgentsGraft vs Host DiseaseHumansInfliximabLiverMaleMiddle AgedTreatment OutcomeConceptsDrug reactionsSerious adverse drug reactionsAdverse drug reactionsHost diseasePatient casesGrand roundsDrug experienceReportInfliximabReviewGraft